BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2456801)

  • 1. Cooperative enhancement of F-cell formation in baboons treated with erythropoietin and hydroxyurea.
    Al-Khatti A; Papayannopoulou T; Knitter G; Fritsch EF; Stamatoyannopoulos G
    Blood; 1988 Aug; 72(2):817-9. PubMed ID: 2456801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons.
    Al-Khatti A; Veith RW; Papayannopoulou T; Fritsch EF; Goldwasser E; Stamatoyannopoulos G
    N Engl J Med; 1987 Aug; 317(7):415-20. PubMed ID: 2441258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
    Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.
    Umemura T; al-Khatti A; Donahue RE; Papayannopoulou T; Stamatoyannopoulos G
    Blood; 1989 Oct; 74(5):1571-6. PubMed ID: 2477080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
    McDonagh KT; Dover GJ; Donahue RE; Nathan DG; Agricola B; Byrne E; Nienhuis AW
    Exp Hematol; 1992 Nov; 20(10):1156-64. PubMed ID: 1385194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of fetal hemoglobin by cell-cycle-specific drugs and recombinant erythropoietin.
    Stamatoyannopoulos G; Veith R; al-Khatti A; Papayannopoulou T
    Am J Pediatr Hematol Oncol; 1990; 12(1):21-6. PubMed ID: 1689967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxurea, stem cell factor, and erythropoietin in combination on fetal hemoglobin in the baboon.
    Lavelle D; Molokie R; Ducksworth J; DeSimone J
    Exp Hematol; 2001 Feb; 29(2):156-62. PubMed ID: 11166454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
    N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal hemoglobin in acute and chronic states of erythroid expansion.
    Blau CA; Constantoulakis P; al-Khatti A; Spadaccino E; Goldwasser E; Papayannopoulou T; Stamatoyannopoulos G
    Blood; 1993 Jan; 81(1):227-33. PubMed ID: 7678067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis.
    Letvin NL; Linch DC; Beardsley GP; McIntyre KW; Miller BA; Nathan DG
    J Clin Invest; 1985 Jun; 75(6):1999-2005. PubMed ID: 2409112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal hemoglobin synthesis in vivo: direct evidence for control at the level of erythroid progenitors.
    Umemura T; Al-Khatti A; Papayannopoulou T; Stamatoyannopoulos G
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9278-82. PubMed ID: 2461566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study.
    Nagel RL; Vichinsky E; Shah M; Johnson R; Spadacino E; Fabry ME; Mangahas L; Abel R; Stamatoyannopoulos G
    Blood; 1993 Jan; 81(1):9-14. PubMed ID: 8417806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
    Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
    Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult.
    Veith R; Papayannopoulou T; Kurachi S; Stamatoyannopoulos G
    Blood; 1985 Aug; 66(2):456-9. PubMed ID: 2410070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of recombinant human erythropoietin in the treatment of thalassemia.
    Rachmilewitz EA; Aker M
    Ann N Y Acad Sci; 1998 Jun; 850():129-38. PubMed ID: 9668535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal hemoglobin induction with butyric acid: efficacy and toxicity.
    Blau CA; Constantoulakis P; Shaw CM; Stamatoyannopoulos G
    Blood; 1993 Jan; 81(2):529-37. PubMed ID: 8422469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia.
    al-Khatti A; Umemura T; Clow J; Abels RI; Vance J; Papayannopoulou T; Stamatoyannopoulos G
    Trans Assoc Am Physicians; 1988; 101():54-61. PubMed ID: 2480020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.